|
只花1分钟注册,更多海淘保健品信息等着你
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
糖尿病-在新的降糖疗法治疗2型糖尿病评估心血管疾病风险2008年10月
9 T) f0 _8 I/ PDiabetes Mellitus — Evaluating Cardiovascular Risk in New 9 v' W, T) l1 R2 V1 N8 E& x. B
Antidiabetic Therapies to " F' w5 P4 o3 a- z; g' [+ d
Treat Type 2 Diabetes2 M) F2 q/ g8 [( b, I2 `
. R5 r A g3 l4 N' h i" P8 H! O这个文件比较大,先翻译一段,有兴趣的TX可以下载自己去看看:! a" T0 E, m( a. A
) y" s2 W5 b0 ~1 |% k6 A+ B+ h4 M- D
I. INTRODUCTION
p3 G0 }6 n4 \( v zThis guidance provides recommendations for the development of drugs and therapeutic biologics
+ Y! t6 d! M5 oregulated within the Center for Drug Evaluation and Research at the Food and Drug 7 O' a. L* n/ \
Administration (FDA) for the treatment of diabetes mellitus.2
) v2 i+ l& a' r$ f1 d6 { Specifically, this guidance makes
7 s' M: q( X$ v: E9 _recommendations about how to demonstrate that a new antidiabetic therapy to treat type 2 0 o& @' E- _6 G! C, ?! w7 F' K
diabetes is not associated with an unacceptable increase in cardiovascular risk.
) o4 v4 c( A- m* E- h' B) [1 b/ {1 {7 n [% `8 ^3 H/ R
I 介绍/ z. v1 p0 ~( N- u9 O% E
本指导提供了FDA关于治疗糖尿病,在药物和治疗性生物制品的开发方面的一些建议。尤其本指导会对II型糖尿病人介绍一种新型的降糖治疗,对心血管方面不会有无法接收的风险提高。% ]! [, z# {1 C3 j7 O8 E! R$ g
* _/ a- T) n9 w5 U4 E$ T; III. BACKGROUND " m; Y% @/ b5 `8 f
Diabetes mellitus has reached epidemic proportions in the United States and more recently - ^3 }0 B6 A- ?3 @/ W+ ]# d" S
worldwide. The morbidity and mortality associated with diabetes is anticipated to account for a
, [: Z) p% b0 ~+ T$ isubstantial proportion of health care expenditures. Although several drug treatments currently
- E4 Z; Z" q$ [3 t6 aare available, we recognize the need for new agents for the prevention and treatment of diabetes / e. G0 X8 v" k: x+ z% n3 V* I
(e.g., development of drugs and therapeutic biologics).
R3 M' y) x: E2 k, O6 C5 k+ q, z r- n# b T' a
II 背景
& N. }. @) J2 a; S9 Z: o在美国乃至全世界,糖尿病已经达到了流行病的程度。由糖尿病引发的发病率和死亡率,在医疗费用支出中已经占相当大的比例。虽然现在已经有很多的治疗药物,我们意识到需要新的药品来阻止和治疗糖尿病(如,药物和治疗性生物制品)。
& G/ Q J/ V: Q4 _9 L0 w5 ~8 C: C
|
|